• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.

作者信息

Lucidarme D, Marteau P, Foucault M, Vautrin B, Filoche B

机构信息

Hôpital Saint-Philibert, Lomme, France.

出版信息

Aliment Pharmacol Ther. 1997 Apr;11(2):335-40. doi: 10.1046/j.1365-2036.1997.126297000.x.

DOI:10.1046/j.1365-2036.1997.126297000.x
PMID:9146772
Abstract

BACKGROUND

Topical treatments with steroids or mesalazine are the most effective treatments for idiopathic proctitis.

AIM

To compare the efficacy and tolerance of mesalazine suppositories vs. hydrocortisone acetate foam in the treatment of acute proctitis.

PATIENTS AND METHODS

242 patients with active idiopathic proctitis were randomized to receive once daily either one Pentasa suppository (mesalazine 1 g) or 100 mg hydrocortisone (Colofoam) for 14-21 days (until remission). Disease activity and tolerance of the treatments were assessed using a daily questionnaire, by physician assessment, and endoscopy score.

RESULTS

Both treatments induced a significant reduction in disease activity. Mesalazine suppositories were significantly more effective than hydrocortisone on rectal blood loss (P = 0.002) and mucus (P = 0.02) parameters, and on the degree of the decrease in endoscopy score (P = 0.02). No significant difference was observed between treatments concerning histology or tolerance.

CONCLUSION

Mesalazine suppositories were as well-tolerated as hydrocortisone foam, but were more effective for some parameters of disease activity.

摘要

相似文献

1
Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.
Aliment Pharmacol Ther. 1997 Apr;11(2):335-40. doi: 10.1046/j.1365-2036.1997.126297000.x.
2
Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.
Scand J Gastroenterol. 1995 Feb;30(2):164-70. doi: 10.3109/00365529509093256.
3
Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.美沙拉嗪栓剂在直肠炎和远端直肠乙状结肠炎中的比较。
Aliment Pharmacol Ther. 1997 Dec;11(6):1053-7. doi: 10.1046/j.1365-2036.1997.00259.x.
4
Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.每周三次使用1克美沙拉嗪缓释栓剂维持溃疡性直肠炎缓解:一项随机双盲安慰剂对照多中心研究。
Gut. 1998 Feb;42(2):195-9. doi: 10.1136/gut.42.2.195.
5
Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository.溃疡性直肠炎的优化管理:何时及如何使用美沙拉嗪栓剂。
Digestion. 2018;97(1):59-63. doi: 10.1159/000484224. Epub 2018 Feb 1.
6
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.布地奈德栓剂治疗急性溃疡性直肠炎有效且安全。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):98-106.e4. doi: 10.1016/j.cgh.2018.04.027. Epub 2018 Apr 24.
7
Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.随机临床试验:美沙拉嗪(美沙拉嗪)栓剂治疗溃疡性结肠炎合并活动性直肠炎症患者的疗效评价——一项安慰剂对照研究。
Aliment Pharmacol Ther. 2013 Aug;38(3):264-73. doi: 10.1111/apt.12362. Epub 2013 Jun 5.
8
[5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].[5-氨基水杨酸灌肠剂(颇得斯安)与醋酸氢化可的松泡沫剂(普乐可复)治疗直肠炎和隐源性直肠乙状结肠炎发作的比较:一项随机多中心对照试验]
Gastroenterol Clin Biol. 1992;16(6-7):558-63.
9
Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.美沙拉嗪(5-氨基水杨酸)栓剂治疗溃疡性直肠炎或远端直肠乙状结肠炎。一项随机对照试验。
Scand J Gastroenterol. 1990 Jul;25(7):663-8. doi: 10.3109/00365529008997590.
10
Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group.
Am J Gastroenterol. 2000 Jan;95(1):166-70. doi: 10.1111/j.1572-0241.2000.01679.x.

引用本文的文献

1
Lyophilized apoptotic vesicles restore DNA damage and mitochondria dysfunction to ameliorate radiation enteritis.冻干凋亡小泡可恢复DNA损伤和线粒体功能障碍,以改善放射性肠炎。
J Nanobiotechnology. 2025 Jul 16;23(1):521. doi: 10.1186/s12951-025-03592-8.
2
Radiation Proctitis: A Review of Pathophysiology and Treatment Strategies.放射性直肠炎:病理生理学与治疗策略综述
Cureus. 2024 Sep 30;16(9):e70581. doi: 10.7759/cureus.70581. eCollection 2024 Sep.
3
A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.
一项多中心、随机研究,旨在评估美沙拉嗪栓剂 1 克睡前和 500 毫克每日两次在活动期轻度至中度溃疡性直肠炎患者中的疗效和安全性。
Dig Dis Sci. 2011 Feb;56(2):513-22. doi: 10.1007/s10620-010-1334-y. Epub 2010 Jul 30.
4
Ulcerative proctitis.溃疡性直肠炎
Clin Colon Rectal Surg. 2004 Feb;17(1):21-7. doi: 10.1055/s-2004-823067.
5
Clinical pharmacokinetics of slow release mesalazine.缓释美沙拉嗪的临床药代动力学
Clin Pharmacokinet. 2000 Aug;39(2):85-97. doi: 10.2165/00003088-200039020-00001.